As part of our protocols we might reach out to your treating doctor for verification or information updates
A small observational study published in JCI Insight (2022) examined individuals with obesity receiving semaglutide who reported reductions in alcohol intake, though the relationship to weight loss requires further investigation in controlled trials
Potential Discounts for Canadian Residents Currently, there are no known discounts for Canadian residents, though you may occasionally find information on various pharmaceutical websites
Beyond that, factors like existing diabetes, cardiovascular risk, kidney function, and history of pancreatitis can all influence which drug is a better fit
The AUD trials do not finish collecting their main results until April 2028, so a submission comes after that and a launch before 2030 looks optimistic